Pharmaceutical Glass Packaging Market Report 2025

The pharmaceutical glass packaging market size has grown strongly in recent years. It will grow from $14.94 billion in 2024 to $16.28 billion in 2025 at a compound annual growth rate (CAGR) of 9%. The growth in the historic period can be attributed to increasing pharmaceutical production, stringent regulations and quality standards, preference for glass's inert nature, global aging population, rise in chronic diseases.

The pharmaceutical glass packaging market size is expected to see rapid growth in the next few years. It will grow to $25.12 billion in 2029 at a compound annual growth rate (CAGR) of 11.4%. The growth in the forecast period can be attributed to continued growth in pharmaceutical sector, advancements in drug delivery, focus on sustainable packaging, demand for biopharmaceuticals, global healthcare infrastructure development. Major trends in the forecast period include growing popularity of ready-to-use packaging, shift towards biodegradable packaging, expansion of emerging markets, collaborations and partnerships.

The expansion of the pharmaceutical industry is expected to drive the growth of the pharmaceutical glass packaging market in the future. The pharmaceutical industry encompasses the discovery, development, and production of medications and drugs. Pharmaceutical glass packaging is utilized to pack and store medications, as well as strong alkalis and acids. For example, in 2023, according to Zippia, a leading U.S.-based information platform, the U.S. pharmaceutical industry accounted for 43.7% of the global pharmaceutical market. Consequently, the growth of the pharmaceutical industry is fueling the demand in the pharmaceutical glass packaging market.

The anticipated increase in the prevalence of chronic diseases is expected to drive the growth of the pharmaceutical glass packaging market in the future. Chronic diseases, characterized by illnesses lasting three months or more and potentially worsening over time, necessitate effective storage, transportation, and administration of medications. Pharmaceutical glass packaging plays a crucial role in meeting these requirements, ensuring the preservation of the stability of active pharmaceutical ingredients in the treatment of chronic diseases. For instance, as of September 2022, data from the World Health Organization (WHO) 2022 Highlights indicates that 74% of all deaths globally - equivalent to 41 million deaths annually - are attributed to noncommunicable diseases (NCDs) or chronic diseases. This highlights the significant impact of chronic diseases on global health. As the prevalence of chronic diseases continues to rise, there is a growing demand for pharmaceutical glass packaging to meet the needs of the pharmaceutical industry. Therefore, the increasing prevalence of chronic diseases stands as a key factor propelling the growth of the pharmaceutical glass packaging market.

Key players in the pharmaceutical glass packaging market are actively pursuing product innovation, with a particular focus on offerings such as Molded glass vials, aiming to gain a competitive advantage in the industry. Molded glass vials are crafted through a process involving the injection of molten glass into a mold, where compressed air aids in the pre-forming process to fill the mold. A case in point is SGD Pharma, an India-based company specializing in glass pharmaceutical packaging services, which introduced Ready-to-Use (RTU) sterile 100 ml molded glass vials in March 2022. The Ready-to-Use (RTU) sterile 100 ml molded glass vials represent a specialized type designed for packaging high-value parenteral drugs in substantial volumes. Noteworthy features include the absence of glass-to-glass contact, thereby minimizing particle generation to safeguard patient safety. These vials are also compatible with various injectable applications and undergo processes such as sterility and depyrogenation to ensure freedom from contaminants. SGD Pharma's strategic move in launching such innovative products underscores the industry's commitment to meeting evolving market demands and prioritizing patient safety through advanced pharmaceutical glass packaging solutions.

Prominent players in the pharmaceutical glass packaging market are actively engaged in product innovation, exemplified by the development of glass jars, as a strategic approach to secure a competitive edge in the industry. Glass jars, characterized by their cylindrical or slightly conical shape, are containers made from glass, ceramic, or plastic, featuring a wide mouth or opening that can be sealed with a lid, screw cap, or lug cap. A case in point is Stoelzle Pharma, an Austria-based pharmaceutical glass packaging company, which unveiled its PharmaCos packaging line in October 2023. The PharmaCos packaging line introduces a new array of glass jars and bottles, ranging from 5ml to 500ml in amber color and incorporating a screw neck design. Additionally, the line includes flat-shoulder bottles spanning from 20ml to 150ml. The design of this packaging line is tailored to provide a sustainable choice for healthcare products, characterized by high recycled glass contents - 73% recycled content in amber glass and 38% in flint glass. Stoelzle Pharma's strategic move in introducing this innovative product line underscores the industry's commitment to sustainability and meeting the evolving needs of healthcare product packaging through advanced and eco-friendly glass packaging solutions.

In July 2022, Gerresheimer AG, a Germany-based manufacturer of primary packaging products for the pharmaceutical and cosmetics industries, formed a partnership with Stevanato Group for an undisclosed amount. This collaboration aims to develop an innovative ready-to-use (RTU) vial platform for the pharmaceutical industry. Stevanato Group, an Italy-based company, provides drug containment, drug delivery, and diagnostic solutions for the pharmaceutical, biotechnology, and life sciences sectors.

Major companies operating in the pharmaceutical glass packaging market include AGC Inc., Berry Global Inc., Corning Inc., Şişecam, Ardagh Group S.A., O-I Glass Inc., Hoya Corporation, Albéa Group, Nipro Corp, Aptar Group Inc., Bormioli Pharma SpA, Gerresheimer AG, Wheaton Industries Inc., Shandong Pharmaceutical Glass Co Ltd., Hindusthan National Glass & Industries Limited, Yoshino Glass Co Ltd., Stolzle Glass Group, Schott AG, Beatson Clark, Arab Pharmaceutical Glass Co, Acme Vial & Glass Co, United Glass Company, SGD SA, Yamamura Glass Co Ltd., Toyo Glass Co Ltd., NEG Group Co Ltd.

North America was the largest region in the pharmaceutical glass packaging market in 2024. The regions covered in the pharmaceutical glass packaging market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the pharmaceutical glass packaging market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Pharmaceutical glass packaging denotes a category of glass containers crafted from a blend of materials, specifically designed to ensure secure transportation for various acidic and medical substances. The utilization of glass in pharmaceutical packaging offers numerous advantages, primarily due to its exceptional resistance to temperature fluctuations.

The primary types of pharmaceutical glass packaging encompass ampoules, bottles, vials, syringes, cartridges, and various other products. Ampoules are sealed glass containers designed for solutions used in hypodermic injections, and they also serve as packaging for many cosmetic and pharmaceutical products. Pharmaceutical drugs are classified into generics, branded, and biologics, and they are packaged in different glass materials, such as type I, type II, and type III. The applications of pharmaceutical glass packaging include oral, injectable, nasal, and other routes of administration, reflecting the diverse needs of the pharmaceutical industry.

The pharmaceutical glass packaging market research report is one of a series of new reports that provides pharmaceutical glass packaging market statistics, including pharmaceutical glass packaging industry global market size, regional shares, competitors with a pharmaceutical glass packaging market share, detailed pharmaceutical glass packaging market segments, market trends and opportunities, and any further data you may need to thrive in the pharmaceutical glass packaging industry. This pharmaceutical glass packaging market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The pharmaceutical glass packaging market consists of sales of borosilicate glass, treated soda-lime glass, regular soda-lime glass, and general purpose soda-lime. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.